These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 542934)

  • 1. The released proteins from avian thrombocytes.
    Wachowicz B; Krajewski T
    Thromb Haemost; 1979 Dec; 42(4):1289-95. PubMed ID: 542934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects on platelet function of removal of platelet sialic acid by neuraminidase.
    Greenberg J; Packham MA; Cazenave JP; Reimers HJ; Mustard JF
    Lab Invest; 1975 Apr; 32(4):476-84. PubMed ID: 1127870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet antiplasmin: its extrusion during the release reaction, subcellular localization, characterization, and relationship to antiheparin in pig platelets.
    Joist JH; Niewiarowski S; Nath N; Mustard JF
    J Lab Clin Med; 1976 Apr; 87(4):659-69. PubMed ID: 131845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets.
    Koda M; Banno Y; Naganawa T
    Platelets; 2005 Dec; 16(8):482-91. PubMed ID: 16287615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoskeletal changes in platelets induced by thrombin and phorbol myristate acetate (PMA).
    Chen R; Liang N
    Cell Biol Int; 1998; 22(6):429-35. PubMed ID: 10328851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clq inhibition of the interaction of collagen with human platelets.
    Cazenave JP; Assimeh SN; Painter RH; Pachham MA; Mustard JF
    J Immunol; 1976 Jan; 116(1):162-3. PubMed ID: 1245737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UV light-induced changes in washed pig platelets.
    Krajewski T; Wachowicz B; Bończak M; Pietrucha T
    Acta Biochim Pol; 1985; 32(2):155-62. PubMed ID: 4036449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of bovine platelet cationic proteins which inhibit the surface-mediated activation of factor XII and prekallikrein.
    Kodama K; Kato H; Iwanaga S
    J Biochem; 1985 Jan; 97(1):139-51. PubMed ID: 3158644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Low molecular weight and protein dinitrosyl complexes of non-heme iron as inhibitors of platelet aggregation].
    Kuznetsov VA; Mordvintsev PI; Dank EKh; Iurkiv VA; Vanin AF
    Vopr Med Khim; 1988; 34(5):43-6. PubMed ID: 2851211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditions influencing platelet lysis.
    Kinlough-Rathbone RL; Chahil AMAR ; Packham MA; Mustard JF
    Lab Invest; 1975 Mar; 32(3):352-8. PubMed ID: 1123914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathways responsible for platelet hypersensitivity in rats with diabetes. II. Spontaneous diabetes in BB Wistar rats.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):154-8. PubMed ID: 3080539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on pig blood platelet responses to peroxynitrite action.
    Nowak P; Wachowicz B
    Platelets; 2001 Sep; 12(6):376-81. PubMed ID: 11672476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actin-binding ability of the protein with the molecular weight of 47,000 phosphorylated during platelet activation.
    Sasaki A; Hiyoshi M; Hashimoto K; Im T; Tatsumi N; Okuda K
    Biochem Int; 1989 Oct; 19(4):737-44. PubMed ID: 2619746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct electrochemical measurement of nitric oxide released from human platelets.
    Malinski T; Radomski MW; Taha Z; Moncada S
    Biochem Biophys Res Commun; 1993 Jul; 194(2):960-5. PubMed ID: 8343175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo functions of thrombin-treated platelets.
    Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
    Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide.
    Rendu F; Bachelot C; Molle D; Caen J; Guez D
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S57-63. PubMed ID: 7508063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipids released from activated platelets improve platelet aggregation and endothelial cell migration.
    Xiao H; Siddiqui RA; Al-Hassani MH; Sliva D; Kovacs RJ
    Platelets; 2001 May; 12(3):163-70. PubMed ID: 11304418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.